|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/00 | (2006.01) |
| (11) | Number of the document | 2760475 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12768999.0 |
| Date of filing the European patent application | 2012-09-26 | |
| (97) | Date of publication of the European application | 2014-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-04 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/US2012/057384 |
| Date | 2012-09-26 |
| (87) | Number | WO 2013/049247 |
| Date | 2013-04-04 |
| (30) | Number | Date | Country code |
| 201161539280 P | 2011-09-26 | US |
| (72) |
BOETTCHER, Brian R., US
CAPLAN, Shari L., US
DANIELS, Douglas S., US
HAMAMATSU, Norio, US
LICHT, Stuart, US
WELDON, Stephen Craig, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sulieti baltymai, skirti metabolinių sutrikimų gydymui |
| FUSION PROTEINS FOR TREATING METABOLIC DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 14 | 289.00 EUR |
| 2026-09-26 |